A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in &#8805;12-Year-Olds.

A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.

Usdan, Lisa; Patel, Sohil; Rodriguez, Hector; Xu, Xia; Lee, Dung-Yang; Finn, Daniel; Wyper, Hayley; Sci, B Biomed; Lowry, Francine S; Mensa, Federico J; Lu, Claire; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S; Türeci, Özlem; Sahin, Ugur; Swanson, Kena A; Gruber, William C; Kitchin, Nicholas.

Usdan L; CNS Healthcare, Memphis, TN, USA.
Patel S; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.
Rodriguez H; Acevedo Clinical Research Associates, Miami, FL, USA.
Xu X; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Lee DY; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Finn D; Kentucky Pediatric/Adult Research, Bardstown, KY, USA.
Sci BB; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.
Lowry FS; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Mensa FJ; BioNTech, Mainz, Germany.
Lu C; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Cooper D; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Koury K; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Anderson AS; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Türeci Ö; BioNTech, Mainz, Germany.
Sahin U; BioNTech, Mainz, Germany.
Swanson KA; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Gruber WC; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Kitchin N; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.